Atrovent
These highlights do not include all the information needed to use ATROVENT HFA safely and effectively. See full prescribing information for ATROVENT HFA. ATROVENT® HFA (ipratropium bromide HFA inhalation aerosol), for oral inhalation use Initial U.S. Approval: 2004
Approved
Approval ID
170e98ef-5560-4068-be7d-e649068eb884
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Oct 5, 2023
Manufacturers
FDA
Boehringer Ingelheim Pharmaceuticals, Inc.
DUNS: 603175944
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
ipratropium bromide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0597-0087
Application NumberNDA021527
Product Classification
M
Marketing Category
C73594
G
Generic Name
ipratropium bromide
Product Specifications
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateOctober 5, 2023
FDA Product Classification
INGREDIENTS (1)
IPRATROPIUM BROMIDEActive
Quantity: 17 ug in 1 1
Code: J697UZ2A9J
Classification: ACTIR